Holdings
Act Capital Management, LLC
As of Jun 30, 2026, Act Capital Management, LLC reported 55 positions worth US$149M. Largest: Krystal Biotech, Inc., Tg Therapeutics, Inc. and Abivax Sa. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Krystal Biotech, Inc. | 45,000 | US$16.7M | −15,477 | Jun 30, 2026 |
| Tg Therapeutics, Inc. | 251K | US$13.8M | +2,000 | Jun 30, 2026 |
| Abivax Sa | 97,000 | US$12.9M | +26,100 | Jun 30, 2026 |
| Chevron Corporation | 75,000 | US$12.4M | no change | Jun 30, 2026 |
| Exxon Mobil Corporation | 78,500 | US$10.7M | +8,500 | Jun 30, 2026 |
| Arrowhead Pharmaceuticals, Inc. | 110K | US$8.97M | +27,600 | Jun 30, 2026 |
| Viking Therapeutics, Inc. | 209K | US$8.16M | no change | Jun 30, 2026 |
| Celcuity Inc. | 62,150 | US$6.5M | −29,525 | Jun 30, 2026 |
| Nektar Therapeutics | 89,300 | US$6.23M | +18,400 | Jun 30, 2026 |
| Tesla, Inc. | 10,800 | US$4.54M | new | Jun 30, 2026 |